Japanese guidelines for food allergy 2020

• Main Authors: Motohiro Ebisawa, Komei Ito, Takao Fujisawa, Yukoh Aihara, Setsuko Ito, Takanori Imai, Yusei Ohshima, Yukihiro Ohya, Hideo Kaneko, Yasuto Kondo, Naoki Shimojo, Mizuho Nagao, Yasunori Ito, Yuzaburo Inoue, Ikuo Okafuji, Sakura Sato, Yoichi Nakajima, Hajime Nishimoto, Tatsuki Fukuie, Masaki Futamura, Tetsuharu Manabe, Noriyuki Yanagida, Yoshiyuki Yamada, Atsuo Urisu
• Format: Article
• Language: English
• Published: Elsevier 2020-07-01
• Series: Allergology International
• Subjects: Food allergy; Guidelines; Oral food challenge; Oral immunotherapy; Prevention
• Online Access: http://www.sciencedirect.com/science/article/pii/S1323893020300368
• ISSN: 1323-8930

Five years have passed since the Japanese Pediatric Guideline for Food Allergy (JPGFA) was first revised in 2011 from its original version. As many scientific papers related to food allergy have been published during the last 5 years, the second major revision of the JPGFA was carried out in 2016. In this guideline, food allergies are generally classified into four clinical types: (1) neonatal and infantile gastrointestinal allergy, (2) infantile atopic dermatitis associated with food allergy, (3) immediate-type of food allergy (urticaria, anaphylaxis, etc.), and (4) special forms of immediate-type of food allergy such as food-dependent exercise-induced anaphylaxis and oral allergy syndrome (OAS). Much of this guideline covers the immediate-type of food allergy that is seen during childhood to adolescence. Infantile atopic dermatitis associated with food allergy type is especially important as the onset of most food allergies occurs during infancy. We have discussed the neonatal and infantile gastrointestinal allergy and special forms of immediate type food allergy types separately. Diagnostic procedures are highlighted, such as probability curves and component-resolved diagnosis, including the recent advancement utilizing antigen-specific IgE. The oral food challenge using a stepwise approach is recommended to avoid complete elimination of causative foods. Although oral immunotherapy (OIT) has not been approved as a routine treatment by nationwide insurance, we included a chapter for OIT, focusing on efficacy and problems. Prevention of food allergy is currently the focus of interest, and many changes were made based on recent evidence. Finally, the contraindication between adrenaline and antipsychotic drugs in Japan was discussed among related medical societies, and we reached an agreement that the use of adrenaline can be allowed based on the physician's discretion. In conclusion, this guideline encourages physicians to follow the principle to let patients consume causative foods in any way and as early as possible.